Journal of Medicinal Chemistry · 2011 · 27 citations · 19 references
PharmacyChemistryMedicinal ChemistryDrug DesignDrug DiscoveryStructure-activity RelationshipsLead Compound DesignLigand BindingLigand-based DesignProtein-ligand DockingStructure-activity Relationship AnalysisChemical Synthesis Of AnaloguesDe Novo Ligand DesignLigand-based Library DesignMedicinal Chemistry ApplicationsQuinoline ChemistryQuinoline SynthesisStructure-activity Relationships Of ActivatorsStructure-based Ligand Design
As a further development of our large program focused on the medicinal chemistry of translocator protein [TSPO (18 kDa)] ligands, a new class of compounds related to alpidem has been designed using SSR180575, emapunil, and previously published pyrrolo[3,4-b]quinoline derivatives 9 as templates. The designed compounds were synthesized by alkylation of the easily accessible 4-methyl-2-phenyl-1H-pyrazolo[3,4-b]quinolin-3(2H)-one derivatives 13-15 with the required bromoacetamides. Along with the expected 2-(4-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazolo[3,4-b]quinolin-1-yl)acetamide derivatives 10, 2-(4-methyl-3-oxo-2-phenyl-2H-pyrazolo[3,4-b]quinolin-9(3H)-yl)acetamide isomers 11 were isolated and characterized. The high TSPO affinity shown by new pyrazolo[3,4-b]quinoline derivatives 10 and especially 11 leads the way to further expand the chemical diversity in TSPO ligands and provides new templates and structure-affinity relationship data potentially useful in the design of new anxiolytic and neuroprotective agents.
19
Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects
Rainer Rupprecht, Gerhard Rammes, Daniela Eser et al. · Science · 2009 · 321 citations
Medicine, Neuroscience, Pharmacology +14
Peripheral Benzodiazepine Receptor (PBR) in Human Breast Cancer
Vassilios Papadopoulas · 2003 · 278 citations
Medicine, Oncology, Pharmacology +14